Procter & Gamble Hygiene and Health Care Limited announced its unaudited financial results for Q2 2026. Revenue from operations increased to ₹115,017 lakhs. Profit before tax stood at ₹28,178 lakhs, and profit for the period was reported as ₹20,986 lakhs. The results were approved by the Board of Directors on November 6, 2025.
Financial Performance Overview
Procter & Gamble Hygiene and Health Care Limited reported its unaudited financial results for the quarter ended September 30, 2025 (Q2 2026). Here’s a snapshot of the key financial figures:
- Revenue from operations: ₹115,017 lakhs compared to ₹93,703 lakhs in the preceding quarter and ₹113,516 lakhs in the corresponding quarter of the previous year.
- Other Income: ₹990 lakhs.
Profitability Metrics
The company’s profitability metrics for Q2 2026 are as follows:
- Profit before tax: ₹28,178 lakhs.
- Income tax expense: ₹7,192 lakhs.
- Profit for the period: ₹20,986 lakhs.
Earnings Per Share
The basic and diluted earnings per share for the quarter stood at ₹64.65.
Segment Performance
The company operates in two main segments: Health Care Products and Hygiene Products. These segments are aggregated into a single reportable segment: manufacturing, trading, and marketing of Health and Hygiene Products.
Key Balance Sheet Highlights
As of September 30, 2025, key balance sheet figures include:
- Total Equity: ₹93,127 lakhs.
- Total Assets: ₹213,341 lakhs.
Cash Flow Summary
Key highlights from the cash flow statement include:
- Net cash generated from operating activities: ₹51,840 lakhs.
- Net cash generated from / (used in) investing activities: ₹858 lakhs.
- Net cash (used in) financing activities: ₹(21,125) lakhs.
Additional Information
The results were reviewed by the Audit Committee and approved by the Board of Directors on November 6, 2025 and have been subjected to a limited review by the Statutory Auditors of the Company.
Source: BSE
